<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00750451</url>
  </required_header>
  <id_info>
    <org_study_id>AH-05/11</org_study_id>
    <nct_id>NCT00750451</nct_id>
  </id_info>
  <brief_title>Low Molecular Weight Heparin in Recurrent Implantation Failure</brief_title>
  <official_title>Empirical Low Molecular Weight Heparin Administration in the Luteal Phase in Patients With Recurrent Implantation Failures: a Randomized Open Labeled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>V.K.V. American Hospital, Istanbul</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>V.K.V. American Hospital, Istanbul</source>
  <brief_summary>
    <textblock>
      Recurrent implantation failure is the failure to achieve a pregnancy after multiple attempts
      with in vitro fertilization treatment. The reason is usually obscure. Many empirical
      treatments have been offered without substantial evaluation. Heparin is thought to play a
      role in the embryo implantation process beyond its anticoagulation effects. The proposed
      study aims to assess the effectiveness and safety of empirical administration of low
      molecular weight heparin in patients undergoing a new IVF treatment cycle after multiple
      failed attempts.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ongoing pregnancy beyond the 20th gestational week rate</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy rate</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Embryo implantation rate</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Infertility</condition>
  <condition>Fertilization in Vitro</condition>
  <condition>Recurrent Implantation Failure</condition>
  <arm_group>
    <arm_group_label>LMWH</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women in the LMWH arm are administered 1 mg/kg/day subcutaneously low molecular weight heparin after oocyte collection in addition to routine luteal phase support with vaginal progesterone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women in the control arm are administered routine luteal phase support without the addition of LMWH</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>low molecular weight heparin (enoxaparine sodium)</intervention_name>
    <description>1 mg/kg/day subcutaneously in the luteal phase after IVF treatment</description>
    <arm_group_label>LMWH</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>crinone 8% gel</intervention_name>
    <description>routine luteal phase support with progesterone gel</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  History of at least two previously failed fresh embryo transfer cycles

          -  All previously failed cycles to be performed in the American Hospital of Istanbul

          -  Female age â‰¤ 38 years

          -  Fresh ejaculate sperms to be used for ICSI

          -  No hormonal, coagulation, or immunological disorders detected

          -  Normal uterine cavity, as assessed by diagnostic office hysteroscopy or saline
             infusion sonography

          -  Normal female and male peripheral karyotype
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cumhur B Urman, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>American Hospital of Istanbul</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assisted Reproduction Unit of the American Hospital of Istanbul</name>
      <address>
        <city>Istanbul</city>
        <zip>34365</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2008</study_first_submitted>
  <study_first_submitted_qc>September 9, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2008</study_first_posted>
  <last_update_submitted>March 19, 2009</last_update_submitted>
  <last_update_submitted_qc>March 19, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 20, 2009</last_update_posted>
  <keyword>fertilization in vitro</keyword>
  <keyword>assisted reproduction</keyword>
  <keyword>recurrent implantation failure</keyword>
  <keyword>low molecular weight heparin</keyword>
  <keyword>heparin</keyword>
  <keyword>luteal phase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin</mesh_term>
    <mesh_term>Heparin, Low-Molecular-Weight</mesh_term>
    <mesh_term>Dalteparin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

